|
BRIX1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.122040E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.576600E-01 |
| Normal-vs-Stage2 |
6.731600E-01 |
| Normal-vs-Stage3 |
1.204320E-02 |
| Normal-vs-Stage4 |
8.556800E-03 |
| Stage1-vs-Stage2 |
9.079200E-01 |
| Stage1-vs-Stage3 |
2.156200E-02 |
| Stage1-vs-Stage4 |
1.554060E-02 |
| Stage2-vs-Stage3 |
8.618500E-02 |
| Stage2-vs-Stage4 |
1.974140E-02 |
| Stage3-vs-Stage4 |
4.647000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.409190E-01 |
| Normal-vs-AfricanAmerican |
4.424400E-01 |
| Normal-vs-Asian |
1.721390E-01 |
| Caucasian-vs-AfricanAmerican |
5.817400E-01 |
| Caucasian-vs-Asian |
2.899600E-01 |
| AfricanAmerican-vs-Asian |
1.373800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.922800E-01 |
| Normal-vs-Female |
8.758200E-03 |
| Male-vs-Female |
1.555860E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.151800E-01 |
| Normal-vs-Extreme_Weight |
2.416400E-01 |
| Normal-vs-Obese |
1.662960E-01 |
| Normal-vs-Extreme_Obese |
3.153400E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.318600E-01 |
| Normal_Weight-vs-Obese |
9.342200E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.798020E-01 |
| Extreme_Weight-vs-Obese |
6.567800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.865410E-01 |
| Obese-vs-Extreme_Obese |
2.049600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.418100E-03 |
| Normal-vs-Age(41-60Yrs) |
5.369700E-02 |
| Normal-vs-Age(61-80Yrs) |
7.946800E-01 |
| Normal-vs-Age(81-100Yrs) |
6.342600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.383700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.715100E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.888000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.187800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.513400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.561800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.692600E-01 |
| Normal-VS-Type2 PRCC |
2.795600E-01 |
| Normal-VS-KIRP CIMP |
2.821700E-02 |
| Normal-VS-Unclassified PRCC |
4.538600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.429800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.405700E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
5.486600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.019800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.273600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.400500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.883800E-01 |
| Normal-vs-N1 |
4.976200E-04 |
| Normal-vs-N2 |
7.679400E-01 |
| N0-vs-N1 |
5.036900E-04 |
| N0-vs-N2 |
6.544800E-01 |
| N1-vs-N2 |
1.974430E-01 |
|
|
